Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28

Transplantation. 2003 Feb 15;75(3):418-20. doi: 10.1097/01.TP.0000044456.51462.E2.

Abstract

The immunogenicity of human leukocyte antigen (HLA)-A2 versus HLA-A28 was analyzed by antibody production, cytotoxic T-lymphocyte (CTL) induction, and graft survival. We observed that an HLA-A2 mismatched child in HLA-A28 women leads to HLA-A2 specific antibodies in 32% of the women (n=31), whereas in the case of an HLA-A28 child and HLA-A2 women (n=30), no HLA-A28 specific antibodies were found ( P<0.002). Also, the CTL precursor frequencies were significantly lower against HLA-A28 compared with CTLp frequencies against HLA-A2 ( P=0.012). Finally, the kidney graft survival was slightly better in HLA-A2 positive recipients transplanted with HLA-A28 mismatches. We can conclude that single HLA-A28 mismatches are less immunogenic in HLA-A2 individuals compared with single HLA-A2 mismatches in HLA-A28 individuals, which is probably because the mismatched epitopes on the HLA-A2 molecule are unique epitopes, whereas the mismatched epitopes on HLA-A28 are shared by other HLA-A and HLA-B molecules.

MeSH terms

  • Antibodies / blood
  • Epitopes / immunology*
  • Female
  • Fetus / immunology
  • Graft Rejection / immunology*
  • Graft Survival / immunology*
  • HLA-A Antigens / immunology
  • HLA-A2 Antigen / immunology*
  • Histocompatibility Testing
  • Humans
  • In Vitro Techniques
  • Kidney Transplantation / immunology*
  • Pregnancy
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antibodies
  • Epitopes
  • HLA-A Antigens
  • HLA-A2 Antigen
  • HLA-A28 antigen